Allergy Therapeutics plc

AGYTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$17,558$21,676$12,715$13,522
Short-Term Investments$0$0$0$0
Receivables$10,944$8,615$7,285$9,934
Inventory$19,103$11,874$12,744$11,893
Other Curr. Assets-$12,928$0$738$0
Total Curr. Assets$34,677$42,165$33,482$35,349
Property Plant & Equip (Net)$24,258$23,315$23,745$23,392
Goodwill$4,565$3,300$3,317$3,364
Intangibles$1,278$1,214$1,370$1,626
Long-Term Investments$0$0$0$0
Tax Assets$1,513$0$0$0
Other NC Assets$1,252$2,976$2,913$5,346
Total NC Assets$32,866$30,805$31,345$33,728
Other Assets$0$0$0$0
Total Assets$67,543$72,970$64,827$69,077
Liabilities
Payables$4,491$14,233$4,015$20,088
Short-Term Debt$405$503$600$635
Tax Payable$1,427$0$4,734$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$28,502$10,243$9,578$3,434
Total Curr. Liab.$37,329$26,430$20,545$25,272
LT Debt$53,040$36,959$22,500$948
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$68$0$382$0
Other NC Liab.$10,267$11,125$11,319$9,243
Total NC Liab.$68,544$53,690$40,573$17,343
Other Liabilities$0$0$0$0
Cap. Leases$6,644$7,057$7,888$8,267
Total Liabilities$131,426$80,120$61,118$42,615
Equity
Pref Stock$0$0$0$0
Common Stock$6,543$4,776$4,766$4,776
Retained Earnings-$267,831-$210,215-$198,927-$174,689
AOCI$7,343$43,650$43,231$41,703
Other Equity$2,953$0$0$0
Total Equity-$38,703-$7,150$3,709$26,462
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$92,723$72,970$64,827$69,077
Net Debt$35,887$15,786$10,385-$11,939
Allergy Therapeutics plc (AGYTF) Financial Statements & Key Stats | AlphaPilot